• ArtsandLectures twitter avatar
    RT @KCRWinSB: Sex, murder, & mystery join us @ the SB County Courthouse Friday night for The Big Sleep https://t.co/vSIq7xC2FR https://t.co…
    2 hours 37 min ago
  • ucsantabarbara twitter avatar
    Join #UCSB & #TheCousteauFellowship2016 in empowering young filmmakers and activists! https://t.co/PQdTv5hK87 https://t.co/SW0cLTP1kb
    7 hours 13 min ago
  • UCSBengineering twitter avatar
    2015 MAT Alumnus co-created wearable tech alcohol sensors #UCSBengineering #UCSBCOE50 https://t.co/o9vt0bcG1M https://t.co/pQJGypdVpo
    8 hours 24 min ago
  • UCSB_GradPost twitter avatar
    Finding Funding Workshop on August 3 https://t.co/1Cvh6qsDAg #UCSB #ucsbgradpost
    10 hours 48 min ago
  • UCSBengineering twitter avatar
    UCSB Engineers do amazing work. Alum @ntopliffe has designed infrastructure for hospitals around the world. https://t.co/86mcdn1TRK
    14 hours 34 min ago
  • UCSBengineering twitter avatar
    @ntopliffe Very cool work on the new Stanford Hospital, congratulations.
    14 hours 47 min ago
  • UCSBgauchos twitter avatar
    Women's Volleyball Earns AVCA Academic Team Award for Second Straight Year https://t.co/GPlSC2O8wy
    15 hours 14 min ago
  • UCSBgauchos twitter avatar
    Women's Volleyball Earns AVCA Academic Team Award for Second Straight Year https://t.co/GPlSC35JV8
    15 hours 14 min ago

Scientists Make Strides Toward Drug Therapy for Inherited Kidney Disease

Thursday, October 27, 2011 - 17:00
Santa Barbara, CA

Scientists at UC Santa Barbara have discovered that patients with an inherited kidney disease may be helped by a drug that is currently available for other uses. The findings are published in this week's issue of the Proceedings of the National Academy of Sciences.

Over 600,000 people in the U.S., and 12 million worldwide, are affected by the inherited kidney disease known as autosomal-dominant polycystic kidney disease (ADPKD). The disease is characterized by the proliferation of thousands of cysts that eventually debilitate the kidneys, causing kidney failure in half of all patients by the time they reach age 50. ADPKD is one of the leading causes of renal failure in the U.S.

"Currently, no treatment exists to prevent or slow cyst formation, and most ADPKD patients require kidney transplants or lifelong dialysis for survival," said Thomas Weimbs, director of the laboratory at UCSB where the discovery was made. Weimbs is an associate professor in the Department of Molecular, Cellular and Developmental Biology, and in the Neuroscience Research Institute at UCSB.

Recent work in the Weimbs laboratory has revealed a key difference between kidney cysts and normal kidney tissue. They found that the STAT6 signaling pathway –– previously thought to be mainly important in immune cells –– is activated in kidney cysts, while it is dormant in normal kidneys. Cystic kidney cells are locked in a state of continuous activation of this pathway, which leads to the excessive proliferation and cyst growth in ADPKD.

The drug Leflunomide, which is clinically approved for use in rheumatoid arthritis, has previously been shown to inhibit the STAT6 pathway in cells. Weimbs and his team found that Leflunomide is also highly effective in reducing kidney cyst growth in a mouse model of ADPKD.

"These results suggest that the STAT6 pathway is a promising drug target for possible future therapy of ADPKD," said Weimbs. "This possibility is particularly exciting because drugs that inhibit the STAT6 pathway already exist, or are in active development."

 

 


 

 

[RETURN TO TOP]  

 

 

Top image: A polycystic mouse kidney (left) is several times larger than a normal mouse kidney (right).

The tissue architecture of the diseased kidney is destroyed by the growth of numerous cysts.
Credit: Thomas Weimbs and Erin Olsan

 

 

†† Bottom image: Thomas Weimbs with images of mouse polycystic kidney sections.
Credit: George Foulsham, Office of Public Affairs, UCSB

 

Weimbs Laboratory